EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Guangzhou Jointas Chemical Joint Stock Co Ltd (002909) fair value: what the stock is really worth

As of Sep 28, 2026: fair value of Guangzhou Jointas Chemical Joint Stock Co Ltd ¥1.57, price ¥7.46, upside -79.0%, quality 33 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Basic Materials · CN · ISIN CNE100003324

GJ Thin data Sep 24, 2026

Guangzhou Jointas Chemical Joint Stock Co Ltd

002909 · SHE

Structural break: The valuation model sees a lasting decline in earnings power for this stock, the confidence band is broken. Treat the target with caution.

Weakest SetupStrongly overvalued and low quality.

!Fair value ¥1.57 · Strongly overvalued (−79.0%)
!Quality 33/100
!Mixed Growth (revenue 5y +4.8 %/yr)
!Loss-making · -3.3% net margin (TTM)
!Low debt · negative free cash flow
!Trails peers (4/12)
!Narrow moat 12/100
!Evidence only low, so the estimate is less certain
Watch Guangzhou Jointas Chemical Joint Stock Co Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

¥19.16 ¥3.51 Fair Value ¥1.57 Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range ¥3.51 – ¥19.16 · fair‑value band ¥1.17 – ¥2.35 · the ¥7.46 price screens above the ¥1.57 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Guangzhou Jointas Chemical Joint Stock Co in your weekly email

Every Wednesday you see whether Guangzhou Jointas Chemical Joint Stock Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Guangzhou Jointas Chemical Co., Ltd. engages in the research, development, production, and sales of adhesives in China. Its products are used in construction, containers, automobiles/electric vehicles, electronics, transportation, petrochemical equipment, steel structures, and engineering equipment. It sells its products under the Antai and Jitai brands.

Show more

Guangzhou Jointas Chemical Co., Ltd. engages in the research, development, production, and sales of adhesives in China. Its products are used in construction, containers, automobiles/electric vehicles, electronics, transportation, petrochemical equipment, steel structures, and engineering equipment. It sells its products under the Antai and Jitai brands. Guangzhou Jointas Chemical Co., Ltd. was founded in 1989 and is based in Guangzhou, China.

Stock analysis

Guangzhou Jointas Chemical Joint Stock Co Ltd (002909) currently trades at ¥7.46, while our model-based Fair Value estimate is ¥1.57, implying the stock looks roughly 376.0% overvalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of ¥1.48 per share, and 0 of the 6 models we run sit above the ¥7.46 price.

Bear case: the Earnings-Based group reads lowest at ¥0.1700, and 6 of the 6 models stay below the price. Evidence for this calculation is low.

Scenario range: ¥1.17 (bear) to ¥2.35 (bull), the price of ¥7.46 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 33/100 (below-average quality), in the Basic Materials sector.

Mixed Growth: Spin-off in 2025: revenue and profit before it include the divested business. Growth is measured afresh from 2025.

Guangzhou Jointas Chemical Joint Stock Co Ltd reported revenue of 1.1B CNY in FY2025 versus 1.7B CNY in FY2021, a compound −10.3%/yr. Reported net income was −27.7M CNY in FY2025.

Key figures

Market cap 2.9B CNY (≈ $434M) · P/S ratio 1.85 · EPS (TTM) ¥−0.0900 · Dividend yield 3.2% · Net margin −2.6% · Return on equity −4.0% · Return on assets (EBIT) 1.2% · Operating margin −3.9%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 35 out of 100 (low confidence).

What moves the price

The share trades about 14% below its 52-week high and 75% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −39% fair-value upside, at −79%, 002909 screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely (¥0.1700 to ¥2.31). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear ¥1.17 Fair Value ¥1.57 Bull ¥2.35
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EPV ¥0.1300 ¥0.1700 ¥0.2100 74
ROIC Compounder ¥0.1300 ¥0.1700 ¥0.2100 72
EV/EBITDA ¥1.68 ¥2.31 ¥2.94 67
All 6 models by family
Earnings-Based
EPV ¥0.1300 ¥0.1700 ¥0.2100 74
Multiples
EV/EBIT ¥0.3600 ¥0.5500 ¥0.7400 65
EV/EBITDA ¥1.68 ¥2.31 ¥2.94 67
EV/Revenue ¥0.2800 ¥0.4900 ¥0.7100 52
Asset-Based
NCAV (Graham) ¥1.11 ¥1.48 ¥2.21 54
Economic Profit
ROIC Compounder ¥0.1300 ¥0.1700 ¥0.2100 72

Open the full fair value analysis →

Notify me when 002909 reaches fair value

Put 002909 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 33/100

Of which business quality 34 · Market factors (momentum, volatility) 56

Profitability 15
Margins and returns on capital today
Quality Growth 32
Are margins and returns improving?
Cashflow 15
Earnings quality: real cash, not paper profit
Fin. Strength 29
Balance sheet, leverage, solvency risk
Investment 57
Disciplined investing over empire-building
Low Volatility 58
Calm price path (market factor)
Momentum 53
Price trend over the last 3–12 months (market factor)
52W Momentum 59
Distance to the 52-week high (market factor)
Net Issuance 81
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 55/100
Spin-off in 2025: revenue and profit before it include the divested business. Growth is measured afresh from 2025.
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−8.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.8%
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.0%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
10.9% (2020) → 2.0% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

002909 screens 376% overvalued. Compare with Linde plc →

Compare Guangzhou Jointas Chemical Joint Stock Co Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 714 stocks

Beats the industry median on 4/11 measures
Overall it trails its industry peers.
Valuation
Quality Score 33 · Bottom 25%
Fair Value upside −79.0% · Bottom 25%
Profitability
Return on assets −0.2% · Bottom 25%
Net margin (TTM) −3.3% · Bottom 25%
Operating margin (TTM) −3.9% · Bottom 25%
Growth and dividend
Revenue growth −14.9% · Bottom 25%
Dividend yield (TTM) 3.2% · Top 25%
Balance sheet
Debt / equity 0.25× · Above median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/B 0.50× · Cheapest 25%
P/S (TTM) 0.41× · Cheapest 25%
EV/EBITDA 7.7× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)0 · sector 28
PAST (return on equity)0 · sector 23
HEALTH (low debt)88 · sector 95
DIVIDEND (yield)65 · sector 29

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Linde plc LIN $469.89 $441.72 −6%
The Sherwin-Williams Company SHW $329.10 $151.68 −54%
Ecolab Inc ECL $279.49 $96.56 −65%
Air Products and Chemicals, Inc APD $281.76 $121.30 −57%
Nan Ya Plastics Corporation 1303 238.00 TWD 234.23 TWD −2%
Givaudan SA GIVN CHF 3,447 CHF 1,527 −56%
Wanhua Chemical Group 600309 ¥69.45 ¥68.03 −2%
DSM-Firmenich AG DSFIR CHF 92.30 CHF 29.70 −68%
Asian Paints Limited ASIANPAINT ₹2,444 ₹1,479 −39%
PPG Industries, Inc PPG $107.52 $76.98 −28%

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Guangzhou Jointas Chemical Joint Stock Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/002909

Frequently asked questions

Is Guangzhou Jointas Chemical Joint Stock Co Ltd (002909) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ¥1.57 versus a price of ¥7.46, about −79% upside (overvalued).
What is the fair value of 002909?
Our model-based fair value for Guangzhou Jointas Chemical Joint Stock Co Ltd is ¥1.57 (as of Sep 24, 2026), built from audited fundamentals. The current price: ¥7.46.
What is the quality score of 002909?
Guangzhou Jointas Chemical Joint Stock Co Ltd has a Quality Score of 33/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
Our model-based price target is the fair value of ¥1.57 (as of Sep 24, 2026) from 6 valuation models. Cautious scenario ¥1.17, optimistic scenario ¥2.35. It is a calculation from audited fundamentals, not an analyst target.
What is the Guangzhou Jointas Chemical Joint Stock Co Ltd stock forecast for 2026?
Our models put fair value at ¥1.57, about −79% upside versus a price of ¥7.46 (overvalued). Cautious scenario ¥1.17, optimistic scenario ¥2.35. The calculation is refreshed regularly with new filings.
What is the revenue of Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
Guangzhou Jointas Chemical Joint Stock Co Ltd reported trailing-twelve-month revenue of about 1.0B CNY (latest available figure, as of Sep 24, 2026).
Does Guangzhou Jointas Chemical Joint Stock Co Ltd pay a dividend?
Guangzhou Jointas Chemical Joint Stock Co Ltd currently shows a dividend yield of about 3.24% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Guangzhou Jointas Chemical Joint Stock Co Ltd it is ¥1.57 per share (as of Sep 24, 2026), against a price of ¥7.46. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).
Is Guangzhou Jointas Chemical Joint Stock Co Ltd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 002909 trades above its calculated fair value: price ¥7.46, fair value ¥1.57, a gap of about −79% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 002909?
No. The price is what the market pays today (¥7.46); the fair value is what the company's own numbers justify (¥1.57). For Guangzhou Jointas Chemical Joint Stock Co Ltd the two are ¥5.89 per share apart. That gap is exactly why we show both numbers side by side.
How much is Guangzhou Jointas Chemical Joint Stock Co Ltd worth?
The market values Guangzhou Jointas Chemical Joint Stock Co Ltd at about 2.9B CNY (market capitalisation, as of Sep 24, 2026). Per share that is ¥7.46; our models calculate a fair value of ¥1.57 per share.
What do the bullish and bearish scenarios say about 002909?
Our models span a range for Guangzhou Jointas Chemical Joint Stock Co Ltd: cautious scenario ¥1.17, base ¥1.57, optimistic ¥2.35 per share (as of Sep 24, 2026, price ¥7.46). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
Balance-sheet figures for Guangzhou Jointas Chemical Joint Stock Co Ltd (as of Sep 24, 2026): return on equity −4.0%, debt of 0.25 per unit of equity. They feed the Quality Score of 33/100, which measures business quality independently of the share price.
How far is 002909 from its 52-week high?
Guangzhou Jointas Chemical Joint Stock Co Ltd trades at ¥7.46, about 14% below its 52-week high of ¥8.72 and 75% above the low of ¥4.26 (as of Sep 28, 2026). Distance from the high says nothing about value: that is what the fair value of ¥1.57 is for.
Which stocks are comparable to Guangzhou Jointas Chemical Joint Stock Co Ltd?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Guangzhou Jointas Chemical Joint Stock Co Ltd stock attractive at the current price?
The data as of Sep 24, 2026: price ¥7.46, calculated fair value ¥1.57 (−79%), Quality Score 33/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 002909 calculated?
We run Guangzhou Jointas Chemical Joint Stock Co Ltd through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥1.57, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.9 % above its aggregate fair value. Guangzhou Jointas Chemical Joint Stock Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
The closing price on Sep 28, 2026 was ¥7.46. Our model-based fair value is ¥1.57, about −79% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Guangzhou Jointas Chemical Joint Stock Co Ltd right now?
The price sits above even our optimistic bull case (¥2.35). The favourable scenario is already priced in. Weak quality (33/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (¥1.17 to ¥2.35) leaves room in how you read the outcome.

Key figures of Guangzhou Jointas Chemical Joint Stock Co Ltd

How large is the market capitalisation of Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
The market capitalisation of Guangzhou Jointas Chemical Joint Stock Co Ltd is 2.9B CNY (≈ $434M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
The price-to-sales ratio of Guangzhou Jointas Chemical Joint Stock Co Ltd is 1.85 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
Earnings per share at Guangzhou Jointas Chemical Joint Stock Co Ltd are ¥−0.0900. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
The dividend yield of Guangzhou Jointas Chemical Joint Stock Co Ltd is 3.2%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
The net margin of Guangzhou Jointas Chemical Joint Stock Co Ltd is −2.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
The return on equity (ROE) of Guangzhou Jointas Chemical Joint Stock Co Ltd is −4.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
On an EBIT basis the return on assets of Guangzhou Jointas Chemical Joint Stock Co Ltd is 1.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
The operating margin of Guangzhou Jointas Chemical Joint Stock Co Ltd is −3.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
Revenue at Guangzhou Jointas Chemical Joint Stock Co Ltd is growing −14.9% versus a year earlier (3y avg −9.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Guangzhou Jointas Chemical Joint Stock Co Ltd (002909)?
Earnings per share at Guangzhou Jointas Chemical Joint Stock Co Ltd are growing −54.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Guangzhou Jointas Chemical Joint Stock Co Ltd (002909) generate?
The free cash flow of Guangzhou Jointas Chemical Joint Stock Co Ltd is −141M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Guangzhou Jointas Chemical Joint Stock Co Ltd (002909) carry?
The net debt of Guangzhou Jointas Chemical Joint Stock Co Ltd is 511M CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Guangzhou Jointas Chemical Joint Stock Co Ltd in the live analysis

One click puts Guangzhou Jointas Chemical Joint Stock Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.